References
1. O’Malley D: T-cell large granular leukemia and related proliferations . Am J Clin Pathol 2007, 127(6) :850-859.
2. Lamy T, Loughran TP, Jr.: How I treat LGL leukemia .Blood 2011, 117 (10):2764-2774.
3. Sanikommu SR, Clemente MJ, Chomczynski P, Afable MG, 2nd, Jerez A, Thota S, Patel B, Hirsch C, Nazha A, Desamito J et al :Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL) . Leuk Lymphoma 2018,59 (2):416-422.
4. Zhu Y, Gao Q, Hu J, Liu X, Guan D, Zhang F: Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experience . Leuk Res2020, 90 :106299.
5. Braunstein Z, Mishra A, Staub A, Freud AG, Porcu P, Brammer JE:Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response . Br J Haematol 2020.
6. Dumitriu B, Ito S, Feng X, Stephens N, Yunce M, Kajigaya S, Melenhorst JJ, Rios O, Scheinberg P, Chinian F et al :Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study . The Lancet Haematology 2016, 3 (1):e22-e29.
7. Olson KK, PM; Olson, TL; et al.: Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia .Cancer Biol Ther 2017, 18(5) :290-303.
8. Costa RO, Bellesso M, Chamone DAF, Ruiz MA, Hallack Neto AE, Aldred VL, Pereira J: T-cell large granular lymphocytic leukemia: treatment experience with fludarabine . Clinics 2012,67 (7):745-748.
9. Tse E, Chan JC, Pang A, Au WY, Leung AY, Lam CC, Kwong YL:Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia .Leukemia 2007, 21 (10):2225-2226.
10. Gassner FJ, Weiss L, Geisberger R, Hofbauer JP, Egle A, Hartmann TN, Greil R, Tinhofer I: Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia . Cancer Immunol Immunother 2011, 60 (1):75-85.